| Serial Number | 98347319 |
| Word Mark | CARDIOVASLINE |
| Filing Date | Monday, January 8, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Friday, October 25, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Pseudo Mark | CARDIO VASLINE |
| Goods and Services | Disposable syringes; Medical balloons; Medical devices to treat intravascular sites; Medical guidewires; Medical guidewires and parts and fittings therefor; Medical introducers; Medical needles and introducers; Medical syringes; Medical tubing for drainage, transfusion and administering drugs; Stent delivery systems |
| Translation of Words in Mark | The wording Cardiovasline has no meaning in a foreign language. |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 8, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | Friday, December 8, 2023 |
| First Use In Commerce Date | Friday, December 8, 2023 |
| Party Name | Ningbo DIZEGENS Medical Science Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Ningbo, Zhejiang Prov. 315336 CN |
| Event Date | Event Description |
| Monday, January 8, 2024 | NEW APPLICATION ENTERED |
| Thursday, April 25, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 12, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, August 5, 2024 | ASSIGNED TO EXAMINER |
| Monday, August 12, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, August 12, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, October 25, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 25, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 25, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |